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Background
Background

Objective Objective
To evaluate the quality of machine
learning studies in healthcare with a focus
on type 2 diabetes as a domain.

Methods Methods
• 3 published reporting guidelines were
found and combined in Excel (77 items):
TRIPOD, MI-CLAIM, and DOME.
• A comprehensive systematic review by
Fregoso-Aparicio et al. analyzing 90 ML
predictive models for type 2 diabetes
was identified to narrow down a clinical
domain.
• The adherence of each of those 90
papers was scored against the
combined checklist by 3 people
independently.
• For papers read by multiple people, a
consensus was reached on whether
each checklist item should be scored a
0, 0.5, 1, or x for not applicable.
• Mean adherence of each paper was
calculated using the number of items
given a numerical score as the
denominator. 3 different numerators
were used:
• baseline: scores summed
• optimistic: # items scored 0.5 or 1
• pessimistic: # items scored 1
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• The use of machine learning (ML) to
identify patterns in data sets is growing
in various healthcare fields.
• However, reporting standards are highly
variable, which can limit reproducibility
and diminish trust in findings by other
researchers and policy makers.
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Figure 2. Level of transparency of all papers scored from
Tier 1 (complete sharing of the code) to Tier 4 (no sharing).
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Figure 1. Average % adherence of all papers scored to combined checklist, TRIPOD, DOME,
and MI-CLAIM. The mean was calculated in 3 different ways to account for scores of 0.5.
Table 1. Ten checklist items with the highest overall baseline adherence.
ML class. If novel approach, reason is it not previously published.
Whether the model produces a classification or regression.
Specify the objectives, including development or validation of the model or both.
All measures used to assess model performance.
Is the input data type structured or unstructured?
The study design or source of data.
Type of model, all model-building procedures, and method for internal validation.
Medical context and rationale for developing or validating the multivariable
prediction model.
Accuracy, sensitivity, specificity, etc.
All predictors used in developing or validating the multivariable prediction model.

Table 2. Ten checklist items with the lowest overall baseline adherence.
Any actions to blind assessment of the outcome to be predicted.
Any actions to blind assessment of predictors for the outcome and other predictors.
Any model updating arising from the validation, if done.
Yes/no for raw evaluation files.
CPU time of single representative execution on standard hardware.
Reliability and robustness of the model as the underlying data distribution shifts.
The primary metric selected to evaluate the clinical utility of the model, including
the justification for selection.
Source code repository, software container, website URL, license.
Feasibility and significance of model interpretability at the case level.
Yes/no for hyper-parameter configuration and model files.
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• Reporting adherence of each study varies by
checklist.
• Reporting adherence of all examined studies
varies by checklist item from 0% to 100%.
• Difficult to score against checklist items with
compound requirements.
• Different guidelines may have been developed
for different communities, which might explain
poor adherence.
• Several studies used Pima Indians diabetes
dataset but did not refer to each other.
• ML community holds sharing of code as high
ideal, but adherence is poor, which makes it
difficult to compare with baseline models.
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